JP2025522146A5 - - Google Patents

Info

Publication number
JP2025522146A5
JP2025522146A5 JP2025524504A JP2025524504A JP2025522146A5 JP 2025522146 A5 JP2025522146 A5 JP 2025522146A5 JP 2025524504 A JP2025524504 A JP 2025524504A JP 2025524504 A JP2025524504 A JP 2025524504A JP 2025522146 A5 JP2025522146 A5 JP 2025522146A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
approximately
amount ranging
present
alprazolam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025524504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025522146A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/036579 external-priority patent/WO2024010592A1/en
Publication of JP2025522146A publication Critical patent/JP2025522146A/ja
Publication of JP2025522146A5 publication Critical patent/JP2025522146A5/ja
Pending legal-status Critical Current

Links

JP2025524504A 2022-07-08 2022-07-08 不眠症を治療するための医薬組成物および方法 Pending JP2025522146A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2022/036579 WO2024010592A1 (en) 2022-07-08 2022-07-08 Pharmaceutical compositions and methods for treating insomnia

Publications (2)

Publication Number Publication Date
JP2025522146A JP2025522146A (ja) 2025-07-10
JP2025522146A5 true JP2025522146A5 (enExample) 2025-07-17

Family

ID=89453886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025524504A Pending JP2025522146A (ja) 2022-07-08 2022-07-08 不眠症を治療するための医薬組成物および方法

Country Status (7)

Country Link
US (1) US20250205218A1 (enExample)
EP (1) EP4551220A4 (enExample)
JP (1) JP2025522146A (enExample)
CN (1) CN119255803A (enExample)
AU (1) AU2022468585A1 (enExample)
CA (1) CA3261198A1 (enExample)
WO (1) WO2024010592A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12370198B2 (en) 2022-07-08 2025-07-29 La Pharmatech Inc Pharmaceutical compositions and methods for treating psychiatric disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10898493B2 (en) * 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
US20220273637A1 (en) * 2019-07-09 2022-09-01 Universite De Bretagne Occidentale (Ubo) Novel pfar-inhibiting compounds

Similar Documents

Publication Publication Date Title
JP2022180461A5 (enExample)
JP2024074963A5 (enExample)
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
HUE029677T2 (hu) Készítmények centrálisan mediált émelygés és hányás kezelésére
JP2018507243A5 (enExample)
JP2024507810A5 (enExample)
JP2023500032A5 (enExample)
JP2020522560A5 (enExample)
MX2024010637A (es) Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
EA202190544A1 (ru) Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний
JP2023549849A5 (enExample)
JP2016505050A5 (enExample)
RU2011111792A (ru) Применение парацетамола и ибупрофена в лечении
WO2017148129A1 (zh) 一种用于治疗恶病质的药物组合物及其应用
JP2025522146A5 (enExample)
MX2024006270A (es) Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas.
RU2006139819A (ru) Применение симетикона для предрасположенных к запорам пациентов
JP2023544249A5 (enExample)
JP2019535830A5 (enExample)
CN103596565B (zh) 塞克硝唑在口腔感染治疗中的应用
JP2025511402A5 (enExample)
JP2024531799A5 (enExample)
JP2025511401A5 (enExample)
JP2021530568A5 (enExample)
JP2025505261A5 (enExample)